Archive

South Florida’s Interstate 595 P3 project finished years ahead of schedule and with positive results for government and the community, writes Phil Schwab in this brief case study of the initiative. In this brief case study, Schwab (who was the private-sector project manager on the

“Since its introduction, the concept of pay for success (PFS) financing has attracted attention from leaders interested in innovative social financing approaches. The model — which establishes outcomes-driven contracts between government and service providers, with up-front capital from private funders — shines a spotlight on

“The Pay for Success Initiative's Ask an Expert feature connects PFS practitioners directly to Urban experts ask questions regarding topics such as project intervention, project management, and evaluation.” This tool is included in our list of TEN NOTABLE RESOURCES FOR PAY FOR SUCCESS.

“The belief that social problems such as high poverty, low employment, and health disparities are best addressed through cross-sector collaboration — partnerships involving government, business, nonprofits and philanthropies, communities, and/or the public as a whole — has inspired a number of prominent interventions in recent years. As part

“Launched in 2013, Lumina Foundation’s Community Partnership for Attainment (CPA) initiative aimed to deepen the impact of cross-sector, place-based efforts to increase higher education attainment in communities and cities across the country. … The CPA investment prioritized three pillars … This Issue Brief focuses on the second

“Science is increasingly complex and requires cross-sector, multi-disciplinary collaboration to make progress. FasterCures compiled a variety of templates, publications, and other resources from collaboration conveners across sectors to guide these efforts. [Readers can] use the information in this toolkit to ease the pain points in

“No one organization or sector alone can bring a scientific discovery through product development. The process takes years and often requires participation from patient advocates, academia, industry, and government. … Stakeholders in R&D increasingly look to foundations to be the ‘honest brokers’ to lead these